Clinical Trial Update: Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the bleeding profile of Activelle® continuous hormone replacement therapy in postmenopausal women has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Activelle®

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Menopause, Healthy | Phase 4 | Status: COMPLETED